Capitalising on attractive industry tailwinds that have seen the Australian Thoroughbred industry thrive through record prize money which has flowed down to customer spending, Apiam Animal Health Limited (ASX:AHX) is set to open its newest equine hub in Victoria following their acquisition of Victorian Equine Group.

For most pet owners, there is no price too dear for their animal healthcare but with an opportunity to reduce annual expenses most have quickly signed up to the Best Mates program run by Apiam Animal Health Limited (ASX:AHX).

Despite having only received a $700k government grant to build a much needed viral vaccine facility, Apiam Animal Health Limited (ASX:AHX) is already eyeing production within the next 12 months, potentially including one for Japanese Encephalitis which is currently impacting the Australian's pig industry.

As the world emerges from the pandemic which has emphasised the critical importance of vaccination, Apiam Animal Health (ASX:AHX) has identified an opportunity to position Australia as leaders in autogenous vaccine manufacturing.

Apiam Animal Health Limited (ASX:AHX) has been at the forefront of animal health standards of care. But with one eye on their international counterparts, executives at Apiam foresee some major improvements in animal, customer and employee outcomes which will be driven by technology.

Invictus Ops Pty Ltd, a wholly owned subsidiary of NSX-listed VGI Health Technology Limited (NSX:VTL), is pleased to announce that it has contracted Resonance Health Ltd (ASX:RHT) to provide liver-fat quantification services for its clinical study on a potential new treatment for Non-Alcoholic Steatohepatitis.

Ladies and gentlemen, I am pleased to report that BTC Health Limited (ASX:BTC) has achieved a number of milestones over the past 12 months, including a greater penetration of our products within hospitals.

I am pleased to provide you with a detailed update on BTC Health Limited's (ASX:BTC) investments, along with an operational update of BTC's wholly owned investee companies.

The primary objective for BTC Speciality Health is to increase market share through organic growth. New products will continue to be sourced by BioImpact and will enable BTC Speciality Health to expand its product range within pain management and critical care.

Medlab Clinical Ltd (ASX:MDC), an Australian biotech using delivery platforms to enhance medicines is pleased to announce the execution of a Master Services Agreement with WEP Clinical Ltd for the exclusive development and delivery of Named Patient Programmes